Understanding B cell responses in food allergies
Innovations in Functional B Cell Epitope Discovery for Food Allergy
This study is looking at how your immune system's B cells react to different food allergens to understand what makes people allergic, with the hope of finding better treatments for food allergies, especially through a method called oral immunotherapy, and it involves analyzing blood samples from patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project ID | NIH-11205412 on NIH RePORTER |
What this research studies
This research investigates how human B cells respond to different food allergens, focusing on the specific parts of these allergens that trigger allergic reactions. By analyzing the B cell receptors and antibodies from patients with food allergies, the study aims to uncover the variations in immune responses among individuals. The approach includes examining the epitope targets that these B cells recognize, which could lead to better treatments for food allergies, particularly through oral immunotherapy. Patients may have their blood samples analyzed to identify their unique B cell responses.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with food allergies who are willing to participate in blood sample analysis.
Not a fit: Patients without food allergies or those who do not have a specific allergic response to food may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more personalized and effective treatments for individuals with food allergies.
How similar studies have performed: Previous research has shown promise in understanding B cell responses in allergies, suggesting that this approach could yield valuable insights.
Where this research is happening
Stanford, United States
- Stanford University — Stanford, United States (Active)
Researchers
- Principal investigator: Boyd, Scott — Stanford University
- Study coordinator: Boyd, Scott
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.